Boothbay Fund Management, LLC Bridge Bio Pharma, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.6 Billion
- Q3 2024
A detailed history of Boothbay Fund Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 78,151 shares of BBIO stock, worth $2.17 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
78,151
Previous 174,700
55.27%
Holding current value
$2.17 Million
Previous $4.43 Million
55.05%
% of portfolio
0.06%
Previous 0.13%
Shares
9 transactions
Others Institutions Holding BBIO
# of Institutions
290Shares Held
170MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$701 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$698 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$394 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$346 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$169 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.12B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...